Compumedics Limited (ASX: CMP) - Share Price

- Current share price for CMP : $0.255

Compumedics Limited (CMP) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany-based DWL Elektronishe Systeme GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

CMP General Information ⁺

ASX Code	CMP
Website	http://www.compumedics.com.au
Industry/Sector	Health Care Equipment
Market Cap ($M)	50
CMP Share Price	$0.255
Day High	$0.255
Day Low	$0.255
Last Close	$0.255
CMP Share Price Movement	- ( No change )

Prices as at 16:40, 28 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Compumedics Limited (CMP) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Final	0.5¢	100%	23 Nov 2004	20 Dec 2004	-	-	-

See all dividends from Compumedics Limited (CMP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Compumedics Limited (CMP) price-sensitive announcements

CMP - Business Update

Compumedics Limited reported significant growth in FY26, with record revenue of $60.3 mill

Compumedics Limited (CMP)
25 Aug 2026 | 9:07 AM

CMP - Preliminary Final Report

Compumedics Limited reported a significant financial improvement for the fiscal year endin

Compumedics Limited (CMP)
25 Aug 2026 | 9:07 AM

CMP - FY26 Update

Compumedics Limited reported record revenue for FY26, with shipped and invoiced revenue re

Compumedics Limited (CMP)
6 Jul 2026 | 10:43 AM

CMP - Business Update April 2026

Compumedics Limited's business update for April 2026 highlights strong demand across its p

Compumedics Limited (CMP)
21 Apr 2026 | 9:38 AM

Compumedics Limited (CMP) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	Business Update	25 Aug 2026 9:07AM	$0.265	$0.255	fallen by 3.77%
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	Preliminary Final Report	25 Aug 2026 9:07AM	$0.265	$0.255	fallen by 3.77%
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	FY26 Update	6 Jul 2026 10:43AM	$0.240	$0.255	risen by 6.25%
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	Appointment of a Chief Commercial Officer, USA	9 Jun 2026 10:05AM	$0.255	$0.255	fallen by 0%
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	Business Update April 2026	21 Apr 2026 9:38AM	$0.285	$0.255	fallen by 10.53%
Compumedics Limited (CMP) ORDINARY FULLY PAID	Health Care	$51	March 2026 Corporate Presentation	25 Mar 2026 8:20AM	$0.295	$0.255	fallen by 13.56%

CMP Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	Yield (%)	Franking (%)
2026A	$0.21	$0.10	-116.40%	284.50	0.00%	0.0%
2025A	-$1.27	-$0.70	-84.60%	0.00	0.00%	0.0%
2024A	-$2.17	-$4.30	153.80%	0.00	0.00%	0.0%

CMP Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Compumedics Limited (CMP)	$51M	-1.1642	0.0000	0.0000	231.8182	0.0000	0.0000	0.00%	0.00%	0.00%
Cochlear Limited (COH)	$9,009M	-0.3136	0.2540	0.0785	33.5386	26.7454	24.7988	2.50%	2.60%	2.83%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$21,407M	0.1388	0.1653	0.1748	55.1187	47.3008	40.2629	1.19%	1.29%	1.45%
ResMed Inc. (RMD)	$19,154M	9.5922	0.0985	0.0885	21.0311	19.1453	17.5880	1.11%	1.20%	1.30%

CMP Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	1.21	231.80	2.24	0.00
Market	0.35	13.30	1.17	0.85
Sector	0.63	20.90	1.72	3.04

CMP Directors

Name	Position	Start Date
Dr David Burton	Chief Executive Officer, Executive Chairman, Executive Director	23 Nov 1987
Mr David Lawson	Chief Financial Officer, Company Secretary, Executive Director	31 Oct 2013
Mr Rod James North	Non-Executive Director	27 Oct 2022

Compumedics Limited (CMP) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
19 Nov 2024	BURTON, David	Issued	Indirect Shares	178,572	$0.280	$50,000.160
23 Aug 2022	JENSZ, Paul	Buy	Indirect Shares	25,400	$0.296	$7,515.000
2 Mar 2022	JENSZ, Paul	Buy	Indirect Shares	30,300	$0.348	$10,555.690

See all changes in directors' interest & trades for Compumedics Limited (CMP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CMP Management

Name	Position
Warwick Freeman	Chief Technology Office

CMP Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Compumedics Limited (CMP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
98,222,891 (51.10%)	D and DJ Holdings Pty Ltd

CMP Calendar of Events

Date	Event
24 August 2027	Report (Prelim)
24 February 2027	Report (Interim)
29 September 2026	Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us